PACB - Pacific Biosciences Of California Inc.

PACB Stock Chart

PACB Profile

Pacific Biosciences of California, Inc., based in Menlo Park, California, specializes in designing, developing, and manufacturing advanced sequencing systems aimed at solving complex genetic challenges. Founded in 2000 and originally known as Nanofluidics, Inc., the company underwent a transformational rebranding in 2005 to reflect its focus on pioneering biosciences technology.

The core of Pacific Biosciences' offerings lies in its PacBio Systems, which enable the conduct, monitoring, and analysis of biochemical sequencing reactions. These systems are complemented by consumable products such as SMRT cells and a range of reagent kits tailored for specific sequencing workflows. These include template preparation kits for DNA conversion into SMRTbell double-stranded DNA library formats, along with essential molecular biology reagents like ligase, buffers, and exonucleases.

Additionally, Pacific Biosciences provides binding kits featuring modified DNA polymerases designed to bind SMRTbell libraries to polymerases in preparation for sequencing. Its sequencing kits encompass all necessary reagents for on-instrument, real-time sequencing, including phospholinked nucleotides essential for accurate genetic analysis.

The company serves a diverse clientele spanning research institutions, genome centers, pharmaceutical companies, and agricultural firms worldwide. Leveraging a direct sales force in North America and Europe, alongside strategic distribution partnerships across Asia, the Middle East, Africa, and Latin America, Pacific Biosciences continues to advance genomic research and clinical applications through its innovative sequencing technologies.

PACB Revenue Chart

PACB Earnings

Analyst Ratings